Inhibition of p53 transcriptional activity by the S100B calcium-binding protein

被引:119
作者
Lin, J
Blake, M
Tang, C
Zimmer, D
Rustandi, RR
Weber, DJ
Carrier, F
机构
[1] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA
[2] Univ S Alabama, Dept Pharmacol, Mobile, AL 36688 USA
关键词
D O I
10.1074/jbc.M104379200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The levels of S100 Ca2+-binding proteins correlate with the progression of certain tumors, but their role, if any, in carcinogenesis is still poorly understood. S100B protein associates with both the p53 oligomerization domain (residues 325-355) and the extreme C terminus of the tumor suppressor p53 (residues 367-392). Consequently, S100B inhibits p53 tetramer formation and p53 phosphorylation mediated by protein kinase C, on p53 C-terminal end. In this report, we show that the S100B protein decreases p53 DNA binding and transcriptional activity. The effect of S100B is reflected in vivo by a reduced accumulation of p53, p21, and MDM2 protein levels in co-transfection assays and in response to bleomycin. The S100B can still interact with p53 in the absence of p53 extreme C-terminal end and reduce the expression of p53 downstream effector genes. These data indicate that S100B does not require p53 extreme C-terminal end to inhibit p53 activity. Collectively, these findings imply that elevated levels of S100B in tumors such as astrocytomas and gliomas could inhibit p53 functions and contribute to cancer progression.
引用
收藏
页码:35037 / 35041
页数:5
相关论文
共 29 条
  • [11] A MAMMALIAN-CELL CYCLE CHECKPOINT PATHWAY UTILIZING P53 AND GADD45 IS DEFECTIVE IN ATAXIA-TELANGIECTASIA
    KASTAN, MB
    ZHAN, QM
    ELDEIRY, WS
    CARRIER, F
    JACKS, T
    WALSH, WV
    PLUNKETT, BS
    VOGELSTEIN, B
    FORNACE, AJ
    [J]. CELL, 1992, 71 (04) : 587 - 597
  • [12] ONCOGENIC FORMS OF P53 INHIBIT P53-REGULATED GENE-EXPRESSION
    KERN, SE
    PIETENPOL, JA
    THIAGALINGAM, S
    SEYMOUR, A
    KINZLER, KW
    VOGELSTEIN, B
    [J]. SCIENCE, 1992, 256 (5058) : 827 - 830
  • [13] p53: Puzzle and paradigm
    Ko, LJ
    Prives, C
    [J]. GENES & DEVELOPMENT, 1996, 10 (09) : 1054 - 1072
  • [14] MARSTON NJ, 1995, ONCOGENE, V10, P1709
  • [16] OConnor PM, 1997, CANCER RES, V57, P4285
  • [17] EXPRESSION OF CA2+-BINDING PROTEINS OF THE S100 FAMILY IN MALIGNANT HUMAN BREAST-CANCER CELL-LINES AND BIOPSY SAMPLES
    PEDROCCHI, M
    SCHAFER, BW
    MUELLER, H
    EPPENBERGER, U
    HEIZMANN, CW
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1994, 57 (05) : 684 - 690
  • [18] SEQUENCE-SPECIFIC TRANSCRIPTIONAL ACTIVATION IS ESSENTIAL FOR GROWTH SUPPRESSION BY P53
    PIETENPOL, JA
    TOKINO, T
    THIAGALINGAM, S
    ELDEIRY, WS
    KINZLER, KW
    VOGELSTEIN, B
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (06) : 1998 - 2002
  • [19] Rustandi RR, 2000, NAT STRUCT BIOL, V7, P570
  • [20] The S100 family of EF-hand calcium-binding proteins: Functions and pathology
    Schafer, BW
    Heizmann, CW
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 1996, 21 (04) : 134 - 140